Embrace

by Empatica S.R.L.  · Based in Italy → — Medical devices, AI and algorithms for remote patient monitoring
Neurology Sleep Medicine

Varies by product and plan. epimonitor: embraceplus - 1 unit: $399 / €399. subscriptions: basic ($17.40/mo. / €16.90/mo.), standard ($26.90/mo. / €26.90/mo.), plus ($52.90/mo. / €51.90/mo.). academic platform: embraceplus $1,166.40/unit, 3-year platform subscription: $1,166.40, 5-year platform subscription: $1,749.60. enterprise trials: contact empatica team for pricing.
Regulatory Status Disclosed

Overview

Embrace, developed by Empatica Srl, is a groundbreaking wearable biosensor device designed for seizure monitoring, particularly for individuals living with epilepsy. It is worn on the wrist and utilizes advanced artificial intelligence (AI) technology to detect patterns in motion and physiological signals that may be associated with generalized tonic-clonic seizures. These signals include electrodermal activity (EDA), temperature, gyroscope, and accelerometer data.

When a likely convulsive seizure is detected, the Embrace device wirelessly transmits data via Bluetooth to a paired smartphone application (Alert App), which then contacts designated caregivers through calls and text messages, including the user’s location, for prompt assistance.

Beyond seizure detection, Embrace also provides continuous monitoring and analysis of an individual’s sleep, rest, and physical activity, offering valuable insights into their lifestyle and overall well-being. This data is stored and accessible through a companion application (Mate App).

While Embrace2 is no longer available for purchase, its services (Alert App, Mate App) remain active for current users. Empatica has launched EpiMonitor, which utilizes the EmbracePlus wearable, as its newest epilepsy monitoring solution with enhanced features and extended battery life.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Generalized tonic-clonic seizure detection
  • Automated caregiver alerts (calls and SMS)
  • Electrodermal activity (EDA) monitoring
  • Accelerometer and gyroscope for motion tracking
  • Skin temperature sensing
  • Sleep tracking and analysis
  • Physical activity monitoring
  • Seizure history logging
  • Water-resistant design
  • AI-powered advanced machine learning algorithms

Use Cases

  • Epilepsy monitoring for patients (adults and children 6+)
  • Caregiver support and immediate alerts
  • Remote patient monitoring
  • Clinical trials and academic research (via Empatica Health Monitoring Platform)
  • Digital biomarker development
  • Tracking sleep and physical activity patterns

What Physicians Need to Know

Seizure Detection
EpiMonitor, an FDA-cleared epilepsy monitoring system, provides real-time seizure alerts for generalized tonic-clonic seizures in adults and children aged 6 and older.
Neurodegenerative Disease Screening
Empatica offers Parkinson's Monitoring (WellPD), which provides continuous, objective insight into Parkinson's motor symptoms using CE-marked wearable technology and validated PKG measures.
Mobile Notification System
EpiMonitor includes a companion smartphone app for real-time seizure alerts, designed to provide peace of mind and independence for patients and caregivers.
Physician Tip

Empatica's platform offers FDA-cleared and CE-marked medical wearables (EmbracePlus, EmbraceMini) for continuous, remote physiological data collection. For epilepsy, EpiMonitor provides real-time alerts for generalized tonic-clonic seizures. For Parkinson's, WellPD offers continuous monitoring of motor symptoms with validated PKG measures. The platform is suitable for clinical trials, academic research, and patient monitoring, providing digital biomarkers and raw sensor data access.

The Empatica Health Monitoring Platform is designed for an end-to-end remote monitoring solution in clinical trials, allowing collection and monitoring of raw data and digital biomarkers. It includes a Cloud API for Clinical Trials and provides Data Access Keys for downloading raw sensor and digital biomarker data for further analysis.

Details

Category Neurology AI, Wearables & Remote Monitoring (RPM)
Pricing Varies by product and plan. epimonitor: embraceplus - 1 unit: $399 / €399. subscriptions: basic ($17.40/mo. / €16.90/mo.), standard ($26.90/mo. / €26.90/mo.), plus ($52.90/mo. / €51.90/mo.). academic platform: embraceplus $1,166.40/unit, 3-year platform subscription: $1,166.40, 5-year platform subscription: $1,749.60. enterprise trials: contact empatica team for pricing.
DeploymentCloud
Mobile App1
Compliance
BAA AvailableUnknown
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated
SOC 2 No AI-estimated
GDPR Yes AI-estimated
Integrations
EHR Not specified
Specialties Neurology, Sleep Medicine

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2018-12-20K181861 510(k)Embrace

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Embrace

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Embrace.

No videos found. Search YouTube directly

View all on YouTube

Frequently Asked Questions

The Empatica Health Monitoring Platform is FDA-cleared and provides accurate, continuous health insights. It is designed to collect and monitor raw data and digital biomarkers, adhering to global regulatory requirements including HIPAA, GDPR, and ISO 13485 for data protection and privacy.
Empatica's products are designed for monitoring neurological conditions such as epilepsy, with EpiMonitor providing real-time seizure alerts, and Parkinson's disease, offering continuous monitoring of motor symptoms through validated PKG measures.
The provided text does not mention alternative products or companies. It focuses solely on Empatica's own FDA-cleared and CE-marked medical wearables, EmbracePlus and EmbraceMini, and their associated monitoring platforms.
The text indicates that for Parkinson's Monitoring for Clinics, physicians should contact the Empatica team for pricing information. Enterprise pricing is not self-serve and requires direct inquiry.
While Empatica's devices collect over 300 digital measures and are FDA-cleared, specific limitations regarding data collection or patient populations beyond the stated age range for EpiMonitor (adults and children aged 6 and older) are not detailed in the provided text.
Empatica pioneers digital biomarker development, including the first FDA-cleared digital biomarker in neurology, and offers a large selection of clinically-validated and research-grade digital biomarkers. This is supported by scientific publications and use in hundreds of studies.

Related Tools

syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
Neurophet AQUA AD Plus
Neurophet
Neurology AI
Neurophet AQUA AD Plus is an AI-powered brain imaging analysis software that supports the diagnosis, treatment guidance, and monitoring of Alzheimer's disease by analyzing MRI and PET scans.
myosmart trial kit
Otto Bock Healthcare Products GmbH
Neurology AI
The Ottobock MyoSmart Trial Kit assists clinicians in assessing and fitting advanced neurorehabilitation prosthetic and orthotic solutions.
connectgrip. (560X27-1)
Otto Bock Healthcare Products GmbH
Neurology AI
Otto Bock Healthcare Products GmbH offers advanced prosthetic and orthotic solutions, with 'connectgrip' (560X27-1) likely being a component designed for secure and functional connection within these systems, potentially incorporating intelligent features for enhanced user control.
myosmart.cuff (757M20-2)
Otto Bock Healthcare Products GmbH
Lab & Diagnostics
The myosmart.cuff is a medical device by Otto Bock Healthcare Products GmbH designed for objective measurement of muscle tone, primarily for use in neurological rehabilitation.
myosmart. (13E522)
Otto Bock Healthcare Products GmbH
Neurology AI
myosmart.

See all Neurology AI tools →

More from Empatica S.R.L.

EmbracePlus
Empatica
Drug Discovery & Research
Empatica Care
Empatica
Clinical Decision Support & Reference
Empatica Care is part of the Empatica Health Monitoring Platform, utilizing medical-grade wearables to collect continuous physiological data for remote patient monitoring and clinical research, accessible via a mobile app and web portal.
EpiMonitor
Empatica S.R.L.
Neurology AI

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-18 | First Added: 2026-04-21
AI Tool Finder
AI-powered search. Results may not be comprehensive.